PMC:7161517 / 4105-4245 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T13","span":{"begin":36,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"This raises the question of whether RAS inhibition in cardiovascular patients should be reassessed in the setting of this novel coronavirus."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T42","span":{"begin":36,"end":39},"obj":"Chemical"}],"attributes":[{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"}],"text":"This raises the question of whether RAS inhibition in cardiovascular patients should be reassessed in the setting of this novel coronavirus."}

{"project":"LitCovid-sentences","denotations":[{"id":"T28","span":{"begin":0,"end":140},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This raises the question of whether RAS inhibition in cardiovascular patients should be reassessed in the setting of this novel coronavirus."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T115","span":{"begin":54,"end":68},"obj":"UBERON:0004535"},{"id":"T116","span":{"begin":128,"end":139},"obj":"NCBITaxon:11118"}],"text":"This raises the question of whether RAS inhibition in cardiovascular patients should be reassessed in the setting of this novel coronavirus."}

{"project":"LitCovid-PubTator","denotations":[{"id":"133","span":{"begin":69,"end":77},"obj":"Species"},{"id":"134","span":{"begin":122,"end":139},"obj":"Species"}],"attributes":[{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"Tax:9606"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This raises the question of whether RAS inhibition in cardiovascular patients should be reassessed in the setting of this novel coronavirus."}